Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...

It also took the spot as the 12th leading cause of disability-adjusted life-years (DALYs), with an age-standardized DALY rate ...

Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose ...